Back to mobile site

Canaccord Adams Reiterates Buy on Pharmacopeia (PCOP)

February 29, 2008 12:22 PM EST Send to a Friend
Canaccord Adams reiterates its Buy rating and $8 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login